Profile data is unavailable for this security.
About the company
SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. is principally engaged in the research & development, production and sales of veterinary biological products. The Company’s products mainly include escherichia coli (K88 and K99) gene modified vaccines for piglets, inactivated; porcine reproductive and respiratory syndrome vaccines, live and swine infectious atrophic rhinitis vaccines, inactivated; newcastle disease mild vaccines, living; newcastle disease, infectious bronchitis, egg drop syndrome’76 vaccines, inactivated and infectious bronchitis vaccines, living, among others. The Company distributes its products mainly in China.
- Revenue in CNY (TTM)239.79m
- Net income in CNY44.92m
- Incorporated1981
- Employees295.00
- LocationShanghai Hile Bio-Technology Co LtdNo. 6720Jinhai Highway, Fengxian DistrictSHANGHAI 200021ChinaCHN
- Phone+86 2 160890892
- Fax+86 2 160890800
- Websitehttp://www.hile-bio.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shanghai OPM Biosciences Co Ltd | 254.91m | 49.43m | 4.36bn | 285.00 | 88.47 | 2.02 | -- | 17.10 | 0.4294 | 0.4294 | 2.22 | 18.80 | 0.1095 | 2.07 | 2.54 | 894,431.90 | 2.09 | 4.34 | 2.16 | 4.65 | 58.86 | 58.31 | 19.06 | 23.40 | 19.91 | -- | 0.0315 | 45.38 | -17.41 | 48.34 | -48.72 | -- | 6.09 | -- |
Hunan Warrant Pharmaceutical Co Ltd | 1.45bn | 222.11m | 4.39bn | 1.16k | 19.78 | 2.46 | -- | 3.03 | 2.37 | 2.37 | 15.44 | 19.01 | 0.6713 | 1.50 | 8.93 | 1,246,491.00 | 9.31 | 11.21 | 11.21 | 14.05 | 64.09 | 69.00 | 13.88 | 13.96 | 3.02 | -- | 0.0252 | 8.05 | 10.84 | 18.50 | 15.60 | 19.02 | 24.49 | -- |
Shanghai Haixin Group Co Ltd | 1.11bn | 171.70m | 4.42bn | 760.00 | 35.65 | 1.55 | -- | 3.99 | 0.1422 | 0.1422 | 0.9185 | 3.27 | 0.2246 | 7.19 | 9.32 | 1,458,849.00 | 4.05 | 2.68 | 4.57 | 3.06 | 46.37 | 44.55 | 18.02 | 11.17 | 2.83 | -- | 0.0089 | 36.10 | -17.88 | 1.48 | 1.20 | 4.19 | -10.27 | 13.18 |
Shanghai Hile Bio-Technology Co Ltd | 239.79m | 44.92m | 4.57bn | 295.00 | 103.89 | 3.66 | -- | 19.07 | 0.0669 | 0.0669 | 0.3664 | 1.90 | 0.154 | 1.06 | 2.40 | 812,857.50 | 2.06 | 1.73 | 2.56 | 2.47 | 45.19 | 50.44 | 13.37 | 10.37 | 1.16 | -- | 0.0562 | 23.89 | -19.76 | -1.11 | -48.30 | 24.17 | -41.32 | 23.47 |
Jiangsu Jibeier Pharmaceutical Co Ltd | 889.82m | 233.59m | 4.63bn | 1.45k | 19.69 | 2.36 | -- | 5.20 | 1.24 | 1.24 | 4.74 | 10.37 | 0.426 | 3.13 | 5.33 | 615,794.80 | 11.17 | 9.77 | 12.06 | 10.66 | 87.87 | 88.44 | 26.22 | 23.29 | 6.76 | -- | 0.005 | 30.68 | 31.49 | 12.16 | 41.65 | 17.79 | 112.78 | -- |
InventisBio Co Ltd | 194.13m | -249.28m | 4.69bn | 221.00 | -- | 2.42 | -- | 24.15 | -0.4289 | -0.4289 | 0.3348 | 3.35 | 0.0898 | -- | 1.96 | 878,429.50 | -11.53 | -- | -12.26 | -- | 97.85 | -- | -128.41 | -- | -- | -- | 0.0054 | -- | -- | -- | 41.26 | -- | -- | -- |
Shanghai Haoyuan Chemexpress Co Ltd | 1.97bn | 97.97m | 4.69bn | 3.37k | 47.82 | 1.84 | -- | 2.38 | 0.652 | 0.652 | 13.10 | 16.92 | 0.4845 | 1.01 | 3.91 | 583,547.80 | 2.38 | 7.38 | 3.23 | 9.60 | 42.51 | 47.03 | 4.92 | 13.53 | 0.894 | 3.37 | 0.3013 | 14.37 | 38.44 | 44.33 | -34.18 | 47.24 | 48.95 | -- |
Hunan Fangsheng Pharmaceutical Co Ltd | 1.63bn | 193.23m | 4.78bn | 1.69k | 24.57 | 3.11 | -- | 2.93 | 0.4428 | 0.4428 | 3.72 | 3.49 | 0.5227 | 1.48 | 6.56 | 966,866.90 | 5.93 | 5.39 | 9.72 | 9.37 | 67.75 | 66.91 | 11.34 | 8.95 | 0.5527 | 16.41 | 0.3447 | 46.47 | -9.12 | 9.15 | -34.64 | 20.68 | 23.91 | 4.75 |
GemPharmatech Co Ltd | 638.97m | 157.34m | 4.83bn | 1.51k | 30.67 | 2.26 | -- | 7.55 | 0.3838 | 0.3838 | 1.56 | 5.20 | 0.2617 | 4.11 | 2.36 | 424,282.40 | 6.44 | 9.45 | 7.28 | 11.13 | 66.43 | 70.21 | 24.62 | 28.16 | 4.68 | -- | 0.0592 | 14.68 | 20.45 | 63.48 | -3.48 | -- | 141.38 | -- |
HitGen Inc | 409.13m | 64.05m | 4.85bn | 452.00 | 75.56 | 3.52 | -- | 11.85 | 0.1601 | 0.1601 | 1.02 | 3.44 | 0.241 | 6.70 | 4.84 | 905,165.50 | 3.77 | 4.63 | 4.02 | 5.10 | 51.46 | 58.89 | 15.66 | 20.66 | 14.48 | 360.77 | 0.142 | 19.14 | 12.64 | 19.69 | 61.16 | -1.96 | -6.12 | -- |
Data as of Jun 14 2024. Currency figures normalised to Shanghai Hile Bio-Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 5.05m | 0.78% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 2.08m | 0.32% |
Gfund Management Co., Ltd.as of 31 Dec 2023 | 2.00m | 0.31% |
The Vanguard Group, Inc.as of 30 Apr 2024 | 1.76m | 0.27% |
Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 1.18m | 0.18% |
China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 838.10k | 0.13% |
China Asset Management Co., Ltd.as of 31 Dec 2023 | 579.50k | 0.09% |
Tian Hong Asset Management Co., Ltd.as of 31 Dec 2023 | 551.50k | 0.09% |
China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 465.80k | 0.07% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 460.90k | 0.07% |
More ▼
Data from 31 Dec 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.